| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.23 | 0.0004 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |